Rinvoq (upadacitinib)

pCPA File Number: 22379

Negotiation Status:

Under consideration for negotiation

Indication(s):

For the treatment of adults with active ankylosing spondylitis who have had an inadequate response to a biologic DMARD or when use of those therapies is inadvisable

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

SR0759

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable